MALLORY CARLETTI: Open Payments
NPI 1134593957 · KELLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,618 in 110 payments from 21 companies in 2025. Trend: 2023 $1,493 · 2024 $683 · 2025 $3,618
Food & beverage: $3,438Education: $180
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 19 | $675 |
| Novartis Pharmaceuticals Corporation | 10 | $518 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $348 |
| UCB, Inc. | 10 | $336 |
| Janssen Scientific Affairs, LLC | 2 | $261 |
| Amgen Inc. | 6 | $250 |
| Galderma Laboratories, L.P. | 9 | $235 |
| Regeneron Healthcare Solutions, Inc. | 10 | $211 |
| ABBVIE INC. | 10 | $188 |
| Organon LLC | 7 | $164 |
Products named: DUPIXENT, COSENTYX, Bimzelx, TREMFYA, NEMLUVIO, OTEZLA, Rhapsido, VTAMA.
Industry payments across TX — which companies pay providers there.
